Plain-English translation of NCT06807190 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 1 research guide →This trial is watching how well Awiqli works and how safe it is for people with diabetes when they use it in their normal daily lives in Japan. Awiqli is a medication that your doctor may already have decided is right for you. The study will follow you for about one year to see how the treatment affects your diabetes and to make sure it's working well.
While this medication has already been approved and is available to patients, researchers want to understand how it performs in real-world conditions with many different types of patients. This helps doctors and patients learn more about what to expect and how to use the treatment safely.
You likely qualify if…
You likely don't qualify if…
You would take Awiqli as your doctor prescribes it, just as you normally would. Your doctor will monitor you over about 52 weeks (one year) and track how the medication is working, any side effects, and your overall diabetes control. You'll have regular check-ins with your healthcare team to share how you're doing and to make sure the treatment is safe and effective for you.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Japan